申请人:Shionogi & Co., Ltd.
公开号:US20180118760A1
公开(公告)日:2018-05-03
The present invention provides the following compounds having anti-viral activity.
A
1
is CR
1A
R
1B
, S or O;
A
2
is CR
2A
R
2B
, S or O;
A
3
is CR
3A
R
3B
, S or O;
A
4
is CR
4A
R
4B
, S or O;
the number of hetero atoms among atoms constituting the ring which consists of A
1
, A
2
, A
3
, A
4
, nitrogen atom adjacent to A
1
and carbon atom adjacent to A
1
, is 1 or 2;
R
1A
and R
1B
are each independently hydrogen, halogen, alkyl, or the like;
R
2A
and R
2B
are each independently hydrogen, halogen, alkyl, or the like;
R
3A
and R
3B
are each independently hydrogen, halogen, alkyl, or the like;
R
4A
and R
4B
are each independently hydrogen, halogen, alkyl, or the like;
R
3A
and R
3B
may be taken together to form non-aromatic carbocycle or non-aromatic heterocycle;
X is CH
2
, S or O;
R
1
is each independently halogen, hydroxy, or the like;
m is any integer of 0 to 2; and
n is any integer of 1 to 2.